W.L. Gore & Assoc. begins the payback of the more than $857 million it owes stent graft rival C.R. Bard for patent infringement with a $36 million royalty check.
Gore could still be on the hook for another $206.5 million, according to the documents.
Earlier this month a federal judge upheld Bard's win in the decade-long legal war between the medical device companies, ruling that Gore's infringement was willful – a decision that opens the door to the possibility of triple damages for bard.